Characteristic N Beta 95% CI1 p-value
PQ-interval 344 0.00 -0.01, 0.01 0.8
Delta LV Mass Index 344 0.00 -0.01, 0.01 0.8
Relative wall thickness 344 0.76 -1.3, 2.8 0.5
LVEF Biplane 344 0.01 0.00, 0.03 0.14
LVEDV biplane 344 0.00 -0.01, 0.00 0.2
LVESV biplane 344 -0.01 -0.02, 0.00 0.2
LV stroke volume 344 -0.01 -0.02, 0.01 0.4
LV cardiac output 253 -0.01 -0.01, 0.00 0.2
AV peakPG 344 0.01 0.00, 0.02 0.028
AV Vmax 344 0.44 0.14, 0.74 0.004
Delta LAVI 344 0.02 0.00, 0.03 0.005
LV internal diastolic diameter 344 -0.03 -0.06, 0.01 0.11
Interventricular septum diameter 344 -0.04 -0.17, 0.08 0.5
TAPSE 344 0.00 -0.05, 0.05 >0.9
LAFB (Left anterior fascicular block) 344
    No
    Yes 0.78 -0.73, 2.3 0.3
LVOT Vmax 344 -0.41 -1.5, 0.68 0.5
Previous Cardiac Surgery 344
    No
    Yes -0.07 -0.69, 0.55 0.8
RBBB 344
    No
    Yes -0.80 -1.6, 0.05 0.064
LBBB 344
    No
    Yes 0.33 -0.71, 1.4 0.5
Atrial fibrillation/Atrial flutter 344
    No
    Yes -0.36 -0.90, 0.18 0.2
Heart faillure 344
    No
    Yes -0.60 -1.1, -0.06 0.029
Rhythm 344
    Sinus rhythm
    Atrial fibrillation 0.27 -0.36, 0.90 0.4
    Atrial fluttter -4.1 -8.7, 0.64 0.090
    Pacemaker rhythm -0.64 -1.9, 0.61 0.3
QRS-interval 344 0.00 -0.01, 0.01 0.5
Heart Rate 344 0.01 -0.01, 0.02 0.4
Ureum 344 -0.03 -0.08, 0.01 0.2
Natrium 344 -0.06 -0.13, 0.02 0.13
Kalium 344 -0.02 -0.60, 0.57 >0.9
Implanted Valve Size (mm) 344 0.03 -0.04, 0.11 0.4
NT-proBNP 344 0.00 0.00, 0.00 0.4
BMI 344 0.01 -0.04, 0.05 0.8
Valve Type 341
    BE
    SE -0.03 -0.56, 0.50 >0.9
Severe Liver Disease/Cirrhosis 344
    No
    Yes 1.3 -2.0, 4.7 0.4
Hostile Chest 344
    No
    Yes 2.5 -0.22, 5.2 0.071
AV block 344
    no block
    first degree 0.50 -0.31, 1.3 0.2
    second degree 0.18 -3.2, 3.5 >0.9
    third degree -0.73 -3.5, 2.0 0.6
Active Malignancy 344
    No
    Yes -0.25 -1.2, 0.66 0.6
TAVI number 344 0.00 0.00, 0.00 0.6
Age at Time of the Procedure 344 -0.04 -0.07, -0.01 0.021
Gender 344
    Female
    Male 0.48 -0.03, 0.98 0.063
Diabetes 344
    No
    Yes -0.11 -0.66, 0.44 0.7
Hypertension 344
    No
    Yes -0.25 -0.77, 0.26 0.3
Coronary Artery Disease 344
    No
    Yes 0.14 -0.37, 0.64 0.6
COPD 344
    No
    Yes 0.25 -0.34, 0.83 0.4
Previous CVA 344
    No
    Yes -0.57 -1.3, 0.15 0.12
Peripheral Vascular Disease 344
    No
    Yes 0.44 -0.26, 1.1 0.2
Previous Pacemaker 344
    No
    Yes -0.01 -1.0, 1.0 >0.9
Porcelain Aorta 344
    No
    Yes 0.14 -0.86, 1.1 0.8
Severe Pulmonary Hypertension 344
    No
    Yes 0.04 -1.8, 1.8 >0.9
Hb 344 0.21 -0.04, 0.45 0.10
Kreatinine 344 0.00 -0.01, 0.01 0.8
eGFR 344 0.01 -0.01, 0.02 0.4
E mean/lat/sep Pre 344 -0.64 -0.74, -0.55 <0.001
LV Mass Index Pre 344 -0.01 -0.02, 0.00 0.021
E-velocity 344 -0.02 -0.02, -0.01 <0.001
E/e' Selfmade Pre 344 0.08 0.04, 0.12 <0.001
AV VTI 344 0.01 0.00, 0.02 0.14
LVOT VTI 344 -0.01 -0.05, 0.04 0.8
AVA VTI Pre 344 -0.51 -0.97, -0.05 0.029
LVOT 344 0.04 -0.09, 0.17 0.5
Access Route 344
    Transfemoral
    Transapical 0.34 -0.54, 1.2 0.5
    Direct-aortic -0.08 -0.88, 0.71 0.8
diff 344 -0.03 -0.22, 0.17 0.8
LAVI biplane/A4C/A2C Pre 344 0.00 -0.02, 0.01 0.4
Delta E/e' 147 -0.15 -0.19, -0.11 <0.001
Delta E/e' Selfmade 238 -0.15 -0.18, -0.12 <0.001
Atrial Fibrillation Classification 99
    Paroxysmal
    Persistent 1.2 -0.87, 3.2 0.3
    Permanent 0.72 -0.62, 2.0 0.3
Heart Faillure Classification 104
    HFpEF
    HFrEF 0.10 -1.7, 1.9 >0.9
    HFmrEF 0.12 -2.1, 2.3 >0.9
    Decompensated AoS -0.10 -1.5, 1.3 0.9
    Unknown -0.96 -3.0, 1.1 0.4
Coronary status at time of TAVI procedure 137
    0-VD
    1-VD -0.16 -1.3, 0.97 0.8
    2-VD 0.03 -1.3, 1.3 >0.9
    3-VD 0.19 -1.3, 1.6 0.8
Left Main Stenosis (>50%) 185
    No
    Yes -3.2 -5.3, -1.2 0.002
Previous Myocardial Infarction 190
    No
    Yes -0.10 -0.96, 0.76 0.8
Previous PCI 191
    No
    Yes 0.17 -0.60, 0.94 0.7
Previous AVR 94
    No
    Yes 0.27 -1.1, 1.7 0.7
Which Aortic Valve Surgery 14
    Bioprothesis (unstented)
    Bioprothese (stented) -0.52 -4.4, 3.4 0.8
    TAVI-Valve 1.1 -4.3, 6.4 0.7
Previous CABG 94
    No
    Yes 0.33 -0.71, 1.4 0.5
E/e' mean/lat/sep Pre 201 0.05 0.01, 0.10 0.028
LV GLS 210 0.02 -0.05, 0.09 0.5
LV internal systolic diameter 232 -0.02 -0.06, 0.02 0.3
e' septal 192 -0.62 -0.74, -0.50 <0.001
e' lateral 186 -0.33 -0.45, -0.21 <0.001
e' mean 151 -0.48 -0.64, -0.31 <0.001
A-velocity 206 0.01 0.00, 0.02 0.074
E/A ratio 188 -0.78 -1.4, -0.13 0.018
E/e' septal 169 0.02 -0.02, 0.06 0.4
E/e' lateral 166 0.02 -0.03, 0.08 0.3
E/e' average 134 0.02 -0.03, 0.08 0.5
LA end-systolic volume (biplane) 156 0.02 0.00, 0.03 0.054
TR peak velocity 235 -0.03 -0.46, 0.40 0.9
TR peak pressure gradient 235 0.00 -0.02, 0.01 0.8
RV internal diastolic diameter 214 -0.03 -0.08, 0.03 0.4
Pulmonary artery systolic pressure 172 0.00 -0.02, 0.02 0.8
RA end-systolic volume (A4C) 221 0.00 -0.01, 0.01 0.7
AV meanPG 215 0.02 -0.01, 0.04 0.2
LA area 223 0.05 -0.02, 0.11 0.2
RA area 221 0.00 -0.06, 0.06 >0.9
1 CI = Confidence Interval